| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) K DJ Autophagy 12 (1), 1, 2016 | 14381* | 2016 |
| Clusterin/apolipoprotein J in human aging and cancer IP Trougakos, ES Gonos The international journal of biochemistry & cell biology 34 (11), 1430-1448, 2002 | 513 | 2002 |
| Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues EA Georgakopoulou, K Tsimaratou, K Evangelou, MPJ Fernandez, ... Aging (Albany NY) 5 (1), 37, 2012 | 462 | 2012 |
| Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications IP Trougakos, K Stamatelopoulos, E Terpos, OE Tsitsilonis, E Aivalioti, ... Journal of Biomedical Science 28 (1), 9, 2021 | 419 | 2021 |
| Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its … N Chondrogianni, FLL Stratford, IP Trougakos, B Friguet, AJ Rivett, ... Journal of Biological Chemistry 278 (30), 28026-28037, 2003 | 415 | 2003 |
| Apoptosis deregulation and the development of cancer multi-drug resistance CM Neophytou, IP Trougakos, N Erin, P Papageorgis Cancers 13 (17), 4363, 2021 | 352 | 2021 |
| Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis IP Trougakos, E Terpos, H Alexopoulos, M Politou, D Paraskevis, ... Trends in molecular medicine 28 (7), 542-554, 2022 | 337 | 2022 |
| Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell … IP Trougakos, A So, B Jansen, ME Gleave, ES Gonos Cancer research 64 (5), 1834-1842, 2004 | 300 | 2004 |
| Molecular chaperones and proteostasis regulation during redox imbalance K Niforou, C Cheimonidou, IP Trougakos Redox biology 2, 323-332, 2014 | 286 | 2014 |
| Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients C Bergamaschi, E Terpos, M Rosati, M Angel, J Bear, D Stellas, ... Cell Reports 36 (6), 2021 | 263 | 2021 |
| Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases IP Trougakos, ES Gonos Free radical research 40 (12), 1324-1334, 2006 | 227 | 2006 |
| Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex IP Trougakos, M Lourda, MH Antonelou, D Kletsas, VG Gorgoulis, ... Clinical cancer research 15 (1), 48-59, 2009 | 213 | 2009 |
| Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology O Nedić, SIS Rattan, T Grune, IP Trougakos Free Radical Research 47 (sup1), 28-38, 2013 | 201 | 2013 |
| The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches-a mini-review IP Trougakos Gerontology 59 (6), 514-523, 2013 | 195 | 2013 |
| Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia—from molecular mechanisms to clinical relevance R Alves, AC Gonçalves, S Rutella, AM Almeida, J De Las Rivas, ... Cancers 13 (19), 4820, 2021 | 189 | 2021 |
| Age‐dependent and gender‐dependent antibody responses against SARS‐CoV‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine E Terpos, IP Trougakos, F Apostolakou, I Charitaki, AD Sklirou, ... American journal of hematology 96 (7), E257, 2021 | 182 | 2021 |
| Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of … E Gkogkou, G Barnasas, K Vougas, IP Trougakos Redox biology 36, 101615, 2020 | 175 | 2020 |
| Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial … IP Trougakos, M Poulakou, M Stathatos, A Chalikia, A Melidonis, ... Experimental gerontology 37 (10-11), 1175-1187, 2002 | 175 | 2002 |
| Natural compounds with anti-ageing activity A Argyropoulou, N Aligiannis, IP Trougakos, AL Skaltsounis Natural product reports 30 (11), 1412-1437, 2013 | 162 | 2013 |
| The emergence of drug resistance to targeted cancer therapies: Clinical evidence AB Sarmento-Ribeiro, A Scorilas, AC Goncalves, T Efferth, IP Trougakos Drug Resistance Updates 47, 100646, 2019 | 158 | 2019 |
Meletios Athanasios DimopoulosNational and Kapodistrian University of Athens, School of MedicineVerified email at med.uoa.gr
